Personal care composition comprising atractylodes lactone-I or a source of atractylodes lactone-I
By using atractylodes lactide-I and hydroxy fatty acids in personal care compositions, the problem of difficulty in effectively reducing skin pigmentation in the prior art is solved, significant inhibition of pigmentation and improvement of skin appearance are achieved, and safe and effective.
Patent Information
- Application Number
- CN202180058311.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2020-09-15
- Filing Date
- 2021-07-14
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2041-07-14
AI Technical Summary
The prior art is difficult to effectively reduce the problem of hyperpigmentation on the skin, and despite the presence of care compositions containing various plant extracts, compositions that provide the benefit of enhancing anti-pigmentation are lacking.
Personal care compositions containing Atractylodes lactide-1 and hydroxy fatty acids with 12 to 20 carbon atoms are used to reduce pigmentation on the skin and improve the appearance of the skin through their synergistic effects.
The composition significantly reduces pigmentation on the skin, provides synergistic benefits of anti-pigmentation, improves skin appearance, and does not toxic to skin cells in a safe and effective concentration range.
Abstract
Description
Technical Field
[0001] The present invention relates to a personal care composition. In particular, the present invention relates to a personal care composition for providing anti-hyperpigmentation benefits. Background Art
[0002] People want to look good and want to maintain their appearance. However, most people will develop various imperfections due to internal / intrinsic factors and external factors. Internal factors include aging, specific skin conditions such as dryness, blemishes, etc. On the other hand, external factors include light exposure, pollution, etc. Both factors can cause undesirable skin imperfections. Therefore, personal care compositions for improving the appearance of the skin are very popular. In particular, personal care compositions containing one or more natural active ingredients are needed because people believe that compounds from nature are better for their overall skin health.
[0003] Hyperpigmentation, mainly caused by sunlight, is one of the defects that affect the appearance of the skin to a considerable extent. Sunlight contains harmful UV rays, which are one of the main components responsible for hyperpigmentation. One of the ways to try to solve the problem of hyperpigmentation is through cosmetic compositions that reduce the melanin content in the skin. At the same time, consumers are increasingly relying on natural ingredients in cosmetic compositions to achieve skin benefits. Therefore, cosmetic compositions with plant ingredients are one of the main topics of concern in the cosmetic industry.
[0004] CN110420153 (Chifeng University, 2019) describes a whitening and freckle-removing Chinese medicine composition, which contains Rehmannia root, Dendrobium officinale, Cornus officinalis, Lycium barbarum, Schisandra chinensis, Peach kernel, Lotus root, Citrus aurantium, Atractylodes, Tangerine peel, White Poria and Tremella fuciformis. It also describes a Chinese medicine cream and a preparation method thereof. The composition is said to inhibit melanin deposition.
[0005] CN110664676 (Jian Royal Beauty Health Co Ltd., 2019) describes a cleansing and beautifying water, which contains Atractylodes chinensis extract, Tribulus terrestris extract, Poria cocos extract, licorice extract, glycerin and polyethylene glycol. It also describes that the cleansing and beautifying water adopts a traditional Chinese medicine formula, is non-toxic, anti-allergic, and has less irritation to the skin. It also states that the beauty water has the effects of anti-oxidation, increasing collagen fibers in the skin, and delaying skin aging.
[0006] CN110559195 (Guangzhou Oushudan Biological Tech Co Ltd., 2019) describes a mask powder with whitening and anti-aging functions. It also describes that the mask powder contains Ganoderma lucidum, Rhodiola rosea, Ginkgo biloba, Safflower, Centella asiatica, Ginseng, Atractylodes lancea, Amaranth, Rhizoma Aconiti Lateralis, Licorice, Angelica sinensis, Pearl powder, Pine pollen and Spirulina powder. It describes that the mask powder composition is guided by traditional medicine and provides the effect of rejuvenating the skin.
[0007] WO 2014 / 068470 (SEDERMA, 2014) describes a cosmetic active ingredient comprising at least three plant extracts: Astragalus membranaceus, Bupleurum faclcatum and Atractylodes macrocephala. It also describes that the active ingredient can be incorporated into a topical composition and can be used to improve the appearance by treating and preventing skin aging and imperfections.
[0008] US 2009 / 0041875 (Shiseido Company Ltd., 2009) describes a novel anti-wrinkle composition comprising one or more of Juniper, Baizhu and Coltsfoot extracts as active ingredients.
[0009] Although prior art literature describes compositions comprising various plant extracts, there remains a need to provide a personal care composition comprising active botanical ingredients for providing enhanced anti-hyperpigmentation benefits.
[0010] Purpose of the Invention
[0011] In view of the above circumstances, an object of the present invention is to provide a skin care composition.
[0012] Another object of the present invention is to provide a skin care composition for improving the appearance of skin.
[0013] It is yet another object of the present invention to provide a skin care composition for reducing hyperpigmentation.
[0014] The present inventors have surprisingly discovered that a personal care composition comprising Atractylodes lactone-I and a hydroxy fatty acid can provide synergistic benefits against hyperpigmentation and improve skin appearance, thereby satisfying one or more of the above-mentioned objectives. Summary of the invention
[0015] In a first aspect, the present invention provides a personal care composition comprising:
[0016] a. Atractylodes lactone-I or a source of Atractylodes lactone-I; and
[0017] b. Hydroxy fatty acids having 12 to 20 carbon atoms.
[0018] In a second aspect, the present invention provides a personal care composition comprising:
[0019] a. Atractylenolide macrocephala extract; and
[0020] b. Hydroxy fatty acids having 12 to 20 carbon atoms.
[0021] In a third aspect, the present invention provides a method for reducing hyperpigmentation on the skin, the method comprising the step of applying a composition according to the first aspect.
[0022] In a fourth aspect, the present invention provides the use of a composition according to the first aspect for reducing hyperpigmentation on the skin.
[0023] In a fifth aspect, the present invention provides a use of a composition comprising atractylodes lactone-I or a source of atractylodes lactone-I and a hydroxy fatty acid having 12 to 20 carbon atoms for reducing hyperpigmentation on the skin.
[0024] By reading the following detailed description, these and other aspects, features and advantages will become clear to those of ordinary skill in the art. For the avoidance of doubt, any feature of one aspect of the present invention can be used for any other aspect of the present invention. The word "comprising" is intended to mean "including", but not necessarily "consisting of" or "consisting of". In other words, the listed steps or options do not need to be exhaustive. It should be noted that the embodiments given in the following description are intended to illustrate the present invention, but are not intended to limit the present invention to these embodiments themselves. Similarly, unless otherwise stated, all percentages are weight / weight percentages. Except in the operating examples and comparative examples, or where otherwise clearly stated, all numbers representing the amount or reaction conditions of the material, the physical properties of the material and / or the use in this specification should be understood to be modified by the word "about". The numerical range represented by "x to y" should be understood to include x and y. When multiple preferred ranges are described in the format of "x to y" for a particular feature, it should be understood that all ranges combining different endpoints are also covered. DETAILED DESCRIPTION OF THE INVENTION
[0026] The disclosure of the present invention herein should be deemed to cover all embodiments found in the claims that are multiple dependent on each other, irrespective of the fact that no multiple dependency or redundancy may be found in the claims.
[0027] Where features are disclosed with respect to a particular aspect of the invention (eg, the composition of the invention), such disclosure should also be considered applicable, mutatis mutandis, to any other aspect of the invention (eg, the method of the invention).
[0028] As used herein, "personal care composition" means a composition that includes topical application to mammals, especially human skin. Such compositions can generally be divided into wash-free or wash-off types, but are preferably wash-free. The composition is formulated as a product applied to the human body, particularly for improving appearance, but can also provide cleaning, odor control or general aesthetic products. The composition of the present invention can be in the form of a liquid, emulsion, cream, foam, scrub, gel or lotion, or applied with an instrument or through a mask or cushion. Non-limiting examples of such compositions include wash-free skin lotions, skin creams, antiperspirants, deodorants, lipsticks, foundations, mascaras, sunless tanning products and sunscreens. The composition of the present invention is preferably a wash-free composition. "Skin" as used herein means skin including the face and body (e.g., neck, chest, back, arms, underarms, hands, legs, buttocks and scalp), especially the part thereof exposed to the sun.
[0029] According to the present invention, a personal care composition for reducing hyperpigmentation is provided. The composition comprises atractylodes lactone-I or a source of atractylodes lactone-I and a hydroxy fatty acid having 12 to 20 carbon atoms.
[0030] Atractylodes lactone-I is a phytoactive found in the rhizome of the plant from which Atractylodes macrocephala is derived. The term "phytoactive" preferably refers to a compound present in a plant that provides a specific benefit such as analgesia, anti-inflammatory benefits, acts as an antioxidant, etc. In practice, the phytoactive is extracted from the plant, or in some cases, the plant extract itself is used in a composition that provides a benefit.
[0031] The term "source" as used above preferably refers to a substance comprising the active ingredient. In the context of the present invention, the source of Atractylodes macrolide-I includes extracts comprising Atractylodes macrolide-I derived from plants or parts of plants such as roots, rhizomes, stems, leaves, flowers, etc. It also includes any blend or mixture comprising Atractylodes macrolide-I as one of the ingredients.
[0032] Preferably, the amount of atractylodes lactone-I is 0.01-15 wt %, more preferably 0.02-10 wt %, even more preferably 0.05-7.5 wt %, most preferably 0.1-5 wt % of the composition. When a source of atractylodes lactone-I is used in the composition, the concentration of the source should be adjusted to the above range according to the active level of atractylodes lactone-I in the source.
[0033] Preferably, the atractylodes lactone-I in the composition is derived from a plant extract. Preferably, the plant extract is an extract of Atractylodes macrocephala or Sai-bai-tang (SBT). Preferably, the atractylodes lactone-I is derived from the rhizome of Atractylodes macrocephala.
[0034] The composition of the present invention also comprises a hydroxy fatty acid. A hydroxy fatty acid is a derivative of a fatty acid containing a hydroxyl group at one or more positions. Preferably, the fatty acid is saturated or unsaturated and branched or unbranched. The hydroxy fatty acid used in the present invention has 12 to 20 carbon atoms, preferably 14 to 20 carbon atoms, more preferably 16 to 20 carbon atoms, and most preferably 18 to 20 carbon atoms.
[0035] Preferably, the hydroxy fatty acid is selected from 2-hydroxymyristic acid, 3-hydroxymyristic acid, 2-hydroxypalmitic acid, 3-hydroxypalmitic acid, 12-hydroxystearic acid, 17-hydroxystearic acid and the like.
[0036] Preferably, the hydroxy fatty acid is hydroxystearic acid. The most preferred hydroxystearic acid is 12-hydroxystearic acid (12HSA).
[0037] In the context of the present invention, hydroxy fatty acids are combined with atractylodes lactone-I or a source of atractylodes lactone-I for providing a synergistic benefit against hyperpigmentation on the skin.
[0038] Preferably, the amount of hydroxy fatty acid is 0.1-20% by weight of the composition, more preferably 0.2-15% by weight, still more preferably 0.5-10% by weight, even more preferably 1-10% by weight, still more preferably 2-10% by weight, most preferably 2-10% by weight.
[0039] Preferably, the molar ratio of Atractylodes lactone-I to hydroxy fatty acid in the composition is 1:80 to 80:1, more preferably 1:30 to 30:1, even more preferably 1:10 to 10:1, and most preferably 1:3 to 3:1.
[0040] The composition preferably comprises one or more organic sunscreens. Many organic sunscreens are suitable for use in combination with the essential ingredients of the present invention. Suitable UV-A / UV-B sunscreens include 2-hydroxy-4-methoxybenzophenone, octyl dimethyl para-aminobenzoic acid, digalloyl trioleate, 2,2-dihydroxy-4-methoxybenzophenone, 4-bis(hydroxypropyl)aminobenzoic acid ethyl ester, 2-cyano-3,3-diphenylacrylate-2-ethylhexyl ester, salicylic acid-2-ethylhexyl ester, para-aminobenzoic acid glyceryl ester, 3,3,5-trimethylcyclohexanol water. Salicylate, methyl anthranilate, p-dimethylaminobenzoic acid or aminobenzoic acid ester, 2-ethylhexyl p-dimethylaminobenzoate, 2-phenylbenzimidazole-5-sulfonic acid, 2-(p-dimethylaminophenyl)-5-sulfonic acid benzooxazole acid, p-methoxycinnamic acid-2-ethylhexyl ester, butyl methoxydibenzoylmethane, 2-hydroxy-4-methoxybenzophenone, octyl dimethyl p-aminobenzoic acid and mixtures thereof. The most suitable organic sunscreen is p-methoxycinnamic acid-2-ethylhexyl ester, butyl methoxydibenzoylmethane or mixtures thereof.
[0041] A safe and effective amount of organic sunscreen can be used in the composition of the present invention. The composition preferably comprises 0.1-15 wt %, more preferably 0.1-10 wt % of the organic sunscreen.
[0042] The composition of the present invention preferably comprises other skin benefit agents. Preferably, the skin benefit agent is selected from niacinamide, nicotinic acid or niacinamide, isonicotinamide, pyridine amide, hexylresorcinol and mixtures thereof. If used, the skin benefit agent is preferably present in an amount of 0.1-15% by weight, more preferably 0.2-10% by weight, even more preferably 0.5-5% by weight of the composition.
[0043] The composition may contain other beneficial skin care actives such as retinol, retinyl esters, resorcinol, allantoin, ubiquinone, conjugated linoleic acid or derivatives thereof. Among them, most preferably included in the composition of the present invention is an anti-aging active such as retinol or retinyl esters.
[0044] The composition of the present invention also comprises a cosmetically acceptable carrier which is a water and oil emulsion, which in certain embodiments may be a water-in-oil emulsion. However, the preferred emulsion is an oil-in-water emulsion.
[0045] Preferred hydrophobic materials for use in the oil phase of such emulsions include emollients such as fats, oils, fatty alcohols, fatty acids, soaps, silicone oils, synthetic esters and / or hydrocarbons.
[0046] Silicones can be divided into volatile and non-volatile classes. Volatile silicone oils, if used, are preferably selected from cyclic (cyclomethicones) or linear polydimethylsiloxanes containing from 3 to 9, preferably 4 to 5, silicon atoms.
[0047] Nonvolatile silicones useful as emollient materials include polyalkyl siloxanes, polyalkylaryl siloxanes, and polyether siloxane copolymers. Substantially nonvolatile polyalkyl siloxanes useful herein include, for example, those having a viscosity of about 5×10 at 25° C. -6 Up to 0.1m 2 Preferred non-volatile emollients useful in the compositions of the present invention have a viscosity of about 1×10 -s About 4×10 -4 m 2 / s of polydimethylsiloxane.
[0048] Specific examples of non-silicone emollients include stearyl alcohol, glyceryl monoricinoleate, mink oil, cetyl alcohol, isopropyl isostearate, stearic acid, isobutyl palmitate, isocetyl stearate, oleyl alcohol, isopropyl laurate, hexyl laurate, decyl oleate, octadecane-2-ol, isocetyl alcohol, eicosanol, behenyl alcohol, cetyl palmitate, silicone oils such as dimethicone, di-n-butyl sebacate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, stearic acid Butyl esters, polyethylene glycol, triethylene glycol, lanolin, cocoa butter, corn oil, cottonseed oil, olive oil, palm kernel oil, rapeseed oil, safflower seed oil, evening primrose oil, soybean oil, sunflower seed oil, avocado oil, sesame seed oil, coconut oil, peanut oil, castor oil, acetylated lanolin alcohol, petrolatum, mineral oil, butyl myristate, isostearic acid, palmitic acid, isopropyl linoleate, lauryl lactate, myristyl lactate, decyl oleate, myristyl myristate and mixtures thereof.
[0049] Esters include:
[0050] a) Alkenyl or alkyl esters of fatty acids having 10 to 20 carbon atoms. Examples thereof include isoarachidyl neopentanoate, isodecyl neopentanoate, isononyl isononanoate, cetyl ricinoleate, oleyl myristate, oleyl stearate and oleyl oleate;
[0051] b) ether esters, such as fatty acid esters of ethoxylated fatty alcohols;
[0052] c) Polyol esters. Mono- and di-fatty acid esters of butanediol, ethylene glycol, di- and mono-fatty acid esters of diethylene glycol, mono- and di-fatty acid esters of polyethylene glycol (200-6000), mono- and di-fatty acid esters of propylene glycol, polypropylene glycol 2000 monooleate, polypropylene glycol 2000 monostearate, ethoxylated propylene glycol monostearate, mono- and di-fatty acid esters of glycerol, polyglycerol polyfatty acid esters, ethoxylated glycerol monostearate, 1,3-butylene glycol monostearate, 1,3-butylene glycol distearate, polyoxyethylene polyol fatty acid esters, sorbitan fatty acid esters, and polyoxyethylene sorbitan fatty acid esters are all satisfactory polyol esters. Particularly useful are C1-C 30 Pentaerythritol, trimethylolpropane and neopentyl glycol esters of alcohols. Examples are pentaerythritol tetraethylhexanoate;
[0053] d) wax esters, such as beeswax, spermaceti and triphein;
[0054] e) sterol esters, examples of which are cholesterol fatty acid esters;
[0055] f) sugar esters of fatty acids, such as sucrose polybehenate and sucrose polycottonseed oleate; or
[0056] g) A mixture of two or more of the above (a) to (f).
[0057] Particularly useful are Benzoic acid C is sold under the trademark 12-15 Alkyl esters.
[0058] Suitable hydrocarbons for use in emollients include petrolatum, mineral oil, C 11 -C 13 Isoparaffin, polyalphaolefin, isohexadecane or mixtures thereof.
[0059] The amount of water in the carrier may be, for example, 1-99% by weight of the personal care composition, more preferably 5-90% by weight, even more preferably 35-80% by weight, optimally 40-70% by weight.
[0060] Other materials that may be included in the cosmetically acceptable carrier include solvents, humectants, thickeners, and powders. Examples of each of these types of materials that may be used alone or as a mixture are as follows:
[0061] The solvent includes ethanol, isopropanol, acetone, ethylene glycol monoethyl ether, diethylene glycol monobutyl ether, diethylene glycol monoethyl ether and mixtures thereof.
[0062] Wetting agent includes wetting agent of polyol type.Typical polyol includes polyalkylene glycol, and more preferably alkylene polyol and its derivative, including propylene glycol, dipropylene glycol, polypropylene glycol, polyethylene glycol and its derivative, sorbitol, hydroxypropyl sorbitol, hexylene glycol, 1,3-butylene glycol, isopentyl glycol, 1,2,6-hexanetriol, glycerine, ethoxylated glycerine, propoxylated glycerine and their mixture.The amount of wetting agent can be for example 0.5-50% by weight of said composition, more preferably 1-15% by weight.Most preferably is glycerine (also referred to as glycerol).The amount of glycerol can be for example 0.5-50% by weight of said composition, more preferably 1-35% by weight, most preferably 2-15% by weight.
[0063] A variety of thickeners may be included in the composition. Exemplary but non-limiting thickeners are stearic acid, acrylamide / sodium acryloyldimethyl taurate copolymer ( AVC), hydroxyethyl acrylate / sodium acryloyldimethyl taurate copolymer, aluminum starch octenylsuccinate, polyacrylates (e.g., carbomers, including 980, 1342、Pemulen and Thickeners may be present in an amount of, for example, 0.05-10% by weight, more preferably 0.3-2% by weight of the composition.
[0064] Powders include chalk, talc, Fuller's earth, kaolin, starches, gums, colloidal silica, sodium polyacrylate, tetraalkyl and / or trialkylaryl ammonium montmorillonites, chemically modified magnesium aluminum silicates, organically modified montmorillonite clays, hydrated aluminum silicates, fumed silica, carboxyvinyl polymers, sodium carboxymethylcellulose and ethylene glycol monostearate.
[0065] The personal care composition of the present invention is preferably a skin care composition. More preferably, the composition is preferably an antiperspirant composition or a facial (except eyelids and lips) care composition. The skin care composition refers to a composition suitable for topical application to human skin, including leave-on and rinse-off products. Preferably, the term includes fluids or liquids, particularly moisturizers rather than facial cosmetics. Most preferably, a leave-on composition. The term "leave-on" used in connection with the composition herein refers to a composition that is applied to the skin or rubbed on the skin and left on the skin. The term "rinse-off" used in connection with the composition herein refers to a skin cleanser that is applied to the skin or rubbed on the skin and rinsed off substantially immediately after application. The term "skin" used herein includes the skin on the face (except eyelids and lips), neck, chest, abdomen, back, arms, underarms, hands and legs. Preferably, the term "skin" includes the skin on the face (except eyelids and lips) and underarms. More preferably, it refers to facial skin except lips and eyelids.
[0066] The composition may be formulated in any known form, more preferably in the form of a cream, emulsion or gel.
[0067] The packaging of the composition of the present invention can be jars or tubes and any other forms commonly used for cosmetics, creams, cleansers and emulsion type products. The composition can be applied topically, preferably 1-4 mg of the composition per square centimeter of skin.
[0068] The compositions of the present invention preferably provide cosmetic benefits to the skin of an individual to whom they are topically applied. Examples of cosmetic benefits include reducing the appearance of fine lines, wrinkles, pores and / or blemish spots; even skin tone on a desired skin surface, long-lasting optical effects, or a combination thereof.
[0069] According to the present invention, a personal care composition is provided, which comprises an Atractylodes macrocephala extract and a hydroxy fatty acid having 12 to 20 carbon atoms.
[0070] According to the present invention, there is provided a method for improving the appearance of skin by reducing hyperpigmentation on the skin. The method comprises the step of applying a composition according to the first aspect to a desired skin surface.
[0071] According to the present invention, there is provided the use of a composition according to the first aspect for reducing hyperpigmentation on the skin.
[0072] According to the present invention, there is provided a use of a composition comprising atractylodes lactone-I or a source of atractylodes lactone-I and a hydroxy fatty acid having 12 to 20 carbon atoms for reducing hyperpigmentation on the skin.
[0073] The invention will now be demonstrated by the following non-limiting examples. These examples are intended to be illustrative only and are not intended to limit the scope of the invention in any way. DETAILED DESCRIPTION
[0074] Example
[0075] Material:
[0076] abbreviation Full form supplier AT-I Atractylodes lactone-I Tauto (Category No. E-0114) 12HSA 12-Hydroxystearic acid Sigma (Cat. No. 219967-1G)
[0077] Preparation process of Atractylodes macrocephala extract
[0078] Aqueous co-extracts of Atractylodes macrocephala (root, originating from China) were prepared by conventional water reflux method, wherein the duration of each reflux cycle was 30 minutes. Two such cycles were performed. A rotary evaporator maintained at 60°C was used for vacuum distillation. The aqueous extracts were freeze dried to powder.
[0079] Methods for cell culture and processing
[0080] Normal human epidermal melanocytes (NHEM) (Biocell, Xi’an, China) were grown in melanocyte growth medium (MGM, Promocell, Germany) containing human melanocyte growth supplement (Promocell, Germany). NHEM cells were plated at 4 × 10 4 Cells were seeded in 24-well plates at a density of 10 cells / mL and incubated for 48 hours in an incubator (Thermo Scientific, Model 3111) at 37°C and 5% CO2. After 48 hours, the culture medium was replaced with fresh culture medium containing the test samples (according to Table 1) for the next 72 hours.
[0081] Cytotoxicity Assessment Methods
[0082] At the end of the 72-hour incubation period, cell viability was determined using a cell counting kit-8 (Cell Counting Kit-8, CCK8) method (Dojindo, Japan). In brief, cells were washed once with phosphate buffered saline (PBS) solution. A freshly prepared 10% CCK8 solution was added to each well, including a blank control (carrier control) well without cells. The plate was incubated in a CO2 incubator at 37°C for 2 hours. The absorbance at 450nm was then measured using a TECAN Safire II plate reader.
[0083] As a result, it was found that all the concentrations used in Table 1 were within the cytotoxic limit. This means that none of the concentrations used in the examples were cytotoxic.
[0084] Methods for quantification of melanin content
[0085] After obtaining the CCK8 absorbance reading, the cells were lysed by lysis buffer at 60°C for 1 hour. Then, 50 μL of cell lysate was transferred to a new 96-well plate and the absorbance at 405 nm was measured using a TECAN plate reader. Serial dilutions of pure melanin were prepared as a reference.
[0086] Melanin content was calculated based on the melanin standard curve. Melanin concentration (μg / mL) was then normalized to relative cell viability. Melanin inhibition rate was then calculated using the following equation:
[0087]
[0088] Melanin inhibition data are summarized in Table 2 below.
[0089] Table 2:
[0090] Example deal with Melanin inhibition rate (inhibition %) A Vector control 0±9.38 B 12HSA 5μM 5.6±3.03 C SBT 100ppm 16.9±2.26 D AT-I 5μM 7.8±2.80 1 SBT 100ppm+12HSA 5μM 38.2±6.21 2 AT-I 5μM+12HSA 5μM 31.0±9.11
[0091] As is apparent from the above table, the Examples within the scope of the present invention (Examples 1 and 2) provide synergistic inhibition of melanin content in melanocytes compared to the Examples outside the scope of the present invention (Examples B, C and D).
[0092] Thus, it should be apparent from the foregoing description that the present invention provides a personal care composition for suppressing melanin levels, thereby reducing the appearance of hyperpigmentation on the skin of an individual.
Claims
1. A personal care composition comprising: a. Atractylodes lactone-I or a source of Atractylodes lactone-I; and b. a hydroxy fatty acid having 12 to 20 carbon atoms, wherein The amount of the hydroxy fatty acid is 0.1-20% by weight of the composition; and the amount of the atractylodes lactone-I is 0.01-15% by weight of the composition, and the hydroxy fatty acid is selected from 2-hydroxymyristic acid, 3-hydroxymyristic acid, 2-hydroxypalmitic acid, 3-hydroxypalmitic acid, 12-hydroxystearic acid and 17-hydroxystearic acid.
2. The composition according to claim 1, wherein The amount of the atractylodes lactone-I is 0.02-10% by weight of the composition.
3. The composition according to claim 2, wherein The amount of the atractylodes lactone-I is 0.1-5% by weight of the composition.
4. The composition according to claim 1, wherein The source of Atractylodes lactone-I is a plant extract.
5. The composition according to claim 4, wherein The plant is Atractylodes macrocephala.
6. A composition as claimed in any one of claims 1 to 5, wherein The amount of the hydroxy fatty acid is 1-10% by weight of the composition.
7. The composition of claim 1, wherein The hydroxystearic acid is 12-hydroxystearic acid (12HSA).
8. A composition as described in any one of the preceding claims 1 to 5, wherein The compositions may also contain other skin benefit agents.
9. The composition of claim 8, wherein The skin benefit agent is selected from niacinamide, pyridinamide, isonicotinamide, hexylresorcinol and mixtures thereof.
10. A composition as claimed in any one of claims 1 to 5, wherein The composition comprises 0.1-15% by weight of an organic sunscreen.
11. A composition as claimed in any one of claims 1 to 5, wherein The composition is a leave-on composition in the form of a cream, emulsion or gel.
12. A personal care composition comprising: a. an extract of Atractylodes macrocephala; and b. a hydroxy fatty acid having 12 to 20 carbon atoms; wherein The amount of the hydroxy fatty acid is 0.1-20 weight % of the composition; and the amount of atractylodes lactone-I in the extract of Atractylodes macrocephala is 0.01-15 weight % of the composition, and the hydroxy fatty acid is selected from 2-hydroxymyristic acid, 3-hydroxymyristic acid, 2-hydroxypalmitic acid, 3-hydroxypalmitic acid, 12-hydroxystearic acid and 17-hydroxystearic acid.
13. A method for the non-therapeutic purpose of reducing hyperpigmentation on the skin, the method comprising the step of applying a composition as claimed in any one of claims 1 to 12.
14. Use of a composition as claimed in any one of claims 1 to 12 for the non-therapeutic purpose of reducing hyperpigmentation on the skin.
15. Use of a composition as claimed in any one of claims 1 to 12 for the preparation of a medicament for the treatment of hyperpigmentation on the skin.
